Showing results (271-280 of 1,352) with videos related to

Sort By:
Pageof 136
JACC. Cardiooncology|August 16, 2021
Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary InterventionYasushi Ueki, Benjamin Vögeli, Alexios Karagiannis, et al.
JACC. Cardiovascular Interventions|September 22, 2012
Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography studyLorenz Räber, Sandro Baumgartner, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|February 14, 2024
Non-Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve ReplacementBashir Alaour, Enrico Ferrari, Dik Heg, et al.
Journal of the American College of Cardiology|June 26, 2012
Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantationLutz Buellesfeld, Stefan Stortecky, Dik Heg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2015
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II studyLorenz Räber, Yoshinobu Onuma, Salvatore Brugaletta, et al.
Circulation. Cardiovascular Interventions|June 15, 2016
Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary InterventionThomas Zanchin, Lorenz Räber, Konstantinos C Koskinas, et al.
Minerva Cardioangiologica|November 22, 2017
From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the era of new-generation drug-eluting stentsFabio Magliulo, Raffaele Piccolo, Anna Franzone, et al.
Pageof 136